From: SULFs in human neoplasia: implication as progression and prognosis factors
Gene overexpressed in cancer samples in comparison to their normal tissue counterpart | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cancer sample type | Datasets | SULF1 | SULF2 | Syndecan 1-4 | Glypican 1-6 | CD44 isoforms containing the alternatively spliced exon v3 | Agrin | Betaglycan | Perlecan | Serglycin | Testican 1-3 |
Leukemia | 33 | Yes | No | No | No | No | No | No | Yes | Yes | Yes |
Adrenal cancer | 2 | Yes | No | No | No | No | No | No | No | No | No |
Brain cancer | 23 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
Breast cancer | 44 | Yes | Yes | Yes | No | Yes | No | No | No | No | Yes |
Colon cancer | 12 | Yes | No | No | No | Yes | No | No | No | No | No |
Esophageal cancer | 4 | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
Gastric cancer | 5 | Yes | No | No | No | No | No | No | Yes | No | Yes |
Head & Neck cancer | 5 | Yes | Yes | Yes | Yes | Yes | No | No | Yes | Yes | No |
Liver cancer | 4 | No | Yes | No | No | No | No | No | No | No | No |
Lung cancer | 16 | Yes | No | No | No | No | Yes | No | No | No | Yes |
Mesothelioma | 3 | Yes | No | No | No | No | No | No | No | No | No |
Pancreatic cancer | 6 | Yes | No | Yes | No | No | No | No | Yes | Yes | Yes |
Renal | 11 | Yes | Yes | No | No | Yes | Yes | No | Yes | No | No |
Sarcoma | 11 | Yes | No | No | No | No | No | No | No | No | No |
Skin cancer | 1 | Yes | Yes | No | No | No | No | No | No | No | No |
Testicular cancer | 1 | Yes | Yes | Yes | Yes | No | Yes | No | No | Yes | No |